Home/Catalogue/Peptide Blends/Retatrutide 20mg + Trizepatide 40mg (10ml)
Peptide Blends · Catalogue reference TP-RETATI-043

Retatrutide 20mg + Trizepatide 40mg (10ml)

Retatrutide 20mg + Trizepatide 40mg (10ml) reference material supplied under the Peptide Blends research area, with per-batch COA and release documentation. Supplied as a reference material for laboratory research, with a Certificate of Analysis, analytical method records and lot-level traceability documentation.

Retatrutide 20mg + Trizepatide 40mg (10ml) — Peptide blend reference material, RetatrutideMgT

Representative presentation. Batch-specific appearance, fill volume and label are confirmed on the Certificate of Analysis accompanying the shipment.

Specification

Values below state the catalogue specification. Batch-specific results are issued on the Certificate of Analysis accompanying each shipment. Where a value is marked “per specification”, it is agreed in the quotation before order confirmation.

Catalogue referenceTP-RETATI-043
Item codesRetatrutideMgT
Product designationRetatrutide 20mg + Trizepatide 40mg (10ml)
Sequence classMulti-component peptide
ClassificationPeptide blend
Molecular weightBlend-dependent
Purity specification99% (reverse-phase HPLC, area %)
Identity methodMass spectrometry (ESI)
Physical form60mg*10vials
Research areaPeptide Blends
Application groupingPeptide Blends
Intended useLaboratory research and further manufacturing use only
Minimum order1 unit (catalog) / negotiated (bulk)
Lead time12–36 hours for catalogue items; stated per project for custom work
PricingQuoted against specification, quantity and destination
Volume pricing

Up to 50% below list

Reference TP-RETATI-043
Single unit Standard quoted price
5+ units Bulk rate applied
25+ units Project rate applied
Contract volume Framework terms quoted

Quotations are issued against specification, quantity and destination. The figures above indicate the tiering applied, not a published price list — request a written quotation for the rate that matches your requirement.

Documents

Certificates released for Retatrutide 20mg + Trizepatide 40mg (10ml)

Browse the full COA library

Research use only. Retatrutide 20mg + Trizepatide 40mg (10ml) is supplied as a reference material for laboratory investigation. It is not a medicine, dietary supplement or cosmetic, and is not intended for human or veterinary use. We cannot provide dosing, administration or clinical guidance.

Research context

Retatrutide 20mg + Trizepatide 40mg (10ml) is referenced in published work within laboratory research models. The information below describes how the material is characterised and handled in a laboratory setting; it is not a statement of effect in any living system.

Identity confirmation

Mass spectrometry against the theoretical molecular weight of Blend-dependent, with the observed and theoretical values both recorded on the release document.

Purity determination

Reverse-phase HPLC at the specified wavelength, reported as area percentage against a defined gradient and column, with total impurity area listed separately.

Storage & stability

Lyophilized material should be stored desiccated and protected from light, typically at −20 °C for long-term retention. Stability data supports the retest date on the certificate.

Laboratory handling

Reconstitution and dilution follow the receiving laboratory's own validated procedure. Solubility characteristics are stated on request; handling is for qualified personnel only.

Literature entry points

Retatrutide 20mg + Trizepatide 40mg (10ml) is used as a characterised reference material across published research areas. Rather than quoting individual papers here, we link to live literature searches so that you can read the primary sources and the current state of the evidence yourself. Search terms are open in a new tab.

We supply a characterised material with analytical documentation. We do not make claims about efficacy, and we do not summarise study conclusions on your behalf. Any interpretation of the literature, and any decision about how a material is used, remains with your own scientific review process.

Documentation package

The following documents are prepared for this catalogue reference and enclosed with the shipment. Formats can be adapted to an institutional template at quotation stage.

TOPPEP
Certificate of AnalysisTP-RETATI-043 · Lot 2607C
ProductRetatrutide 20mg + Trizepatide 40mg (10ml) reference material
AppearanceConforms
Identity (MS)Conforms
Purity (RP-HPLC)99% area
Molecular weightBlend-dependent
Form60mg*10vials
Release datePer lot
Retest datePer lot
Certificate of Analysis
Batch record availableReleased
TOPPEP
Certificate of AnalysisTP-RETATI-043 · Lot 2607C
DetectorUV 214 nm
ColumnC18, 4.6 × 250 mm
Gradient0.1% TFA / ACN
Flow rate1.0 mL/min
Purity99% area
Impurity totalReported per lot
Method refQC-HPLC-02
InstrumentQualified HPLC system
HPLC Chromatogram
Batch record availableReleased
TOPPEP
Certificate of AnalysisTP-RETATI-043 · Lot 2607C
IonisationESI positive
Theoretical MWBlend-dependent
Observed MWPer lot
DeviationWithin tolerance
ResultIdentity conforms
Method refQC-MS-01
AcquisitionPer lot
InstrumentCalibrated MS system
Mass Spectrum
Batch record availableReleased
TOPPEP
Certificate of AnalysisTP-RETATI-043 · Lot 2607C
Batch number2607C
Sequence classMulti-component peptide
PurificationPreparative RP-HPLC
FillingSealed vial, desiccated
Unit countPer batch
Storage−20 °C, desiccated
Dispatch recordOn file
Retained sampleYes
Batch Traceability Record
Batch record availableReleased

How to order Retatrutide 20mg + Trizepatide 40mg (10ml)

01

Send the requirement

Quote catalogue reference TP-RETATI-043, the quantity required, the target purity and the destination country. Include your internal reference or tender number if applicable.

02

Receive the quotation

A written quotation returns with specification, documentation package, lead time, shipping terms and a validity period suitable for internal approval. Typical turnaround is 12–36 hours.

03

Confirm and release

On confirmation the batch is allocated, the documentation package is assembled and checked against the order, and dispatch is scheduled against the agreed shipping conditions.

04

Goods-in verification

The shipment arrives with the certificate, method records and lot traceability documentation enclosed, so identity and purity can be verified on receipt without a further request.

Request a specification and quotation

Related reference materials

For research use only. Not for human or veterinary use. Not for diagnostic, therapeutic or household use. This page describes a reference material supplied for laboratory investigation. It contains no dosage information, no administration guidance, no clinical claims and no statement of therapeutic benefit, and none should be inferred from the technical content.

Request a specification and quotation

Send the catalogue reference or target sequence, required purity, quantity and destination on WhatsApp. The procurement desk returns a formal quotation with the documentation package and lead time.

Chat on WhatsApp Procurement guides